Ribavirin and interferon combination for recurrent post-transplant hepatitis C: which benefit beyond 6 months?
- 31 August 2002
- journal article
- editorial
- Published by Elsevier in Journal of Hepatology
- Vol. 37 (2) , 274-276
- https://doi.org/10.1016/s0168-8278(02)00200-3
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The association between hepatitis C infection and survival after orthotopic liver transplantationGastroenterology, 2002
- HCV-related fibrosis progression following liver transplantation: increase in recent yearsJournal of Hepatology, 2000
- European collaborative study on factors influencing outcome after liver transplantation for hepatitis CGastroenterology, 1999
- Hepatitis C virus recurrence after liver transplantationGut, 1999
- QUALITY OF LIFE, FUNCTIONAL STATUS, AND DEPRESSION IN MALE LIVER TRANSPLANT RECIPIENTS WITH RECURRENT VIRAL HEPATITIS CTransplantation, 1999
- High Incidence of Allograft Cirrhosis in Hepatitis C Virus Genotype 1B Infection Following Transplantation: Relationship With Rejection EpisodesHepatology, 1999
- Retransplantation for recurrent hepatitis CLiver Transplantation and Surgery, 1997
- Long-Term Outcome of Hepatitis C Infection after Liver TransplantationNew England Journal of Medicine, 1996
- PRELIMINARY EXPERIENCE WITH α-2b-INTERFERON THERAPY OF VIRAL HEPATITIS IN LIVER ALLOGRAFT RECIPIENTS1,2Transplantation, 1992
- An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B HepatitisScience, 1989